The global Human iPSC Biobanking for Drug Discovery Market is poised for robust growth as pharmaceutical companies increasingly adopt human induced pluripotent stem cell (iPSC) models to improve drug discovery, toxicity testing, and precision medicine research. According to Future Market Insights (FMI), the market is projected to grow from USD 1,479.2 million in 2026 to USD 4,269.1 million by...